Efficacy of OnabotulinumtoxinA in Migraine

Clinical Trial ID NCT04578782

Rank	Title	Journal	Year	PubWeight™‹?›
1	OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial.	Cephalalgia	2010	4.24
2	OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial.	Cephalalgia	2010	3.54
3	Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study.	Headache	2008	1.95
4	Incidence and predictors for chronicity of headache in patients with episodic migraine.	Neurology	2004	1.44
5	Chronic migraine is an earlier stage of transformed migraine in adults.	Neurology	2005	1.20
6	Acute reduction of anandamide-hydrolase (FAAH) activity is coupled with a reduction of nociceptive pathways facilitation in medication-overuse headache subjects after withdrawal treatment.	Headache	2012	0.82
7	Neural Plasticity in Common Forms of Chronic Headaches.	Neural Plast	2015	0.80
8	Modulation of central sensitisation by detoxification in MOH: results of a 12-month detoxification study.	Cephalalgia	2013	0.77